Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table.

Autor: Cosentino F; Cardiology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden., Verma S; Division of Cardiac Surgery, St Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada., Ambery P; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Treppendahl MB; Cardiovascular Diseases, Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark., van Eickels M; Thrombosis & Hematology, Medical Affairs, Bayer AG, Berlin, Germany., Anker SD; Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), and German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany., Cecchini M; Health Division, Organisation for Economic Co-operation and Development (OECD), Paris, France., Fioretto P; Department of Medicine, University of Padova, Padova, Italy., Groop PH; Department of Nephrology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.; Folkhälsan Institute of Genetics, Helsinki, Finland.; Department of Diabetes, Monash University, Melbourne, Australia., Hess D; Department of Physiology and Pharmacology, University of Western Ontario, Robarts Research Institute, London, ON, Canada.; Department of Pharmacology, University of Toronto, Division of Vascular Surgery, St Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada., Khunti K; Leicester Diabetes Centre, University of Leicester, Leicester, UK., Lam CSP; National Heart Centre Singapore, Duke-National University of Singapore, Singapore., Richard-Lordereau I; General Medicine Europe, Amgen Europe, Rotkreutz ZG, Switzerland., Lund LH; Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., McGreavy P; ESC Patients Forum, Sheffield, UK., Newsome PN; National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Sattar N; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Solomon S; Harvard Medical School, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., Weidinger F; 2nd Medical Department with Cardiology and Intensive Care Medicine, Klinik Landstrasse, Vienna, Austria., Zannad F; Université de Lorraine, Inserm Clinical Investigation Center at Institut Lorrain du Coeur et des Vaisseaux, University Hospital of Nancy, Nancy, France., Zeiher A; Cardio Pulmonary Institute, Goethe University of Frankfurt, Frankfurt, Germany.

Publikováno v: European heart journal [Eur Heart J] 2023 Oct 14; Vol. 44 (39), pp. 4141-4156.

Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.

Autor: Mantovani LG; Center for Public Health Research, University of Milan-Bicocca, 20900 Monza, Italy.; Laboratory of Public Health, Istituto Auxologico Italiano-IRCCS, 20165 Milan, Italy., Cozzolino P; Center for Public Health Research, University of Milan-Bicocca, 20900 Monza, Italy., Ferrara P; Center for Public Health Research, University of Milan-Bicocca, 20900 Monza, Italy.; Laboratory of Public Health, Istituto Auxologico Italiano-IRCCS, 20165 Milan, Italy., Virdone S; Thrombosis Research Institute, London SW3 6LR, UK., Camm AJ; Cardiovascular Clinical Academic Group, St. George's University of London, London SW17 0RE, UK., Verheugt FWA; Onze Lieve Vrouwe Gasthuis (OLVG), 1091 AC Amsterdam, The Netherlands., Bassand JP; Thrombosis Research Institute, London SW3 6LR, UK.; Department of Cardiology, University of Besançon, 25030 Besançon, France., Turpie AGG; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada., Hacke W; Department of Neurology, Ruprecht-Karls-University of Heidelberg, 69120 Heidelberg, Germany., Kayani G; Thrombosis Research Institute, London SW3 6LR, UK., Goldhaber SZ; Division of Cardiovascular Medicine, Harvard Medical School, Boston, MA 02115, USA., Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara 259-1193, Japan., Pieper KS; Thrombosis Research Institute, London SW3 6LR, UK., Gersh BJ; Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, NY 55905, USA., Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK., Haas S; Formerly Department of Medicine, Technical University of Munich, 81675 Munich, Germany., van Eickels M; Bayer AG, 13353 Berlin, Germany., Kakkar AK; Thrombosis Research Institute, London SW3 6LR, UK., On Behalf Of The Garfield-Af Investigators

Publikováno v: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2023 Feb 21; Vol. 11 (5). Date of Electronic Publication: 2023 Feb 21.

Van Eickels M, Patten RD, Aronovitz MJ, Alsheikh-Ali A, Gostyla K, Celestin F, Grohe C, Mendelsohn ME, Karas RH. 17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol 2003;41:2084–92

Publikováno v: Journal of the American College of Cardiology. (1):184

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::597b09f1e294c42e9f7fc9eeaae3c074

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial

Autor: Hohnloser, SH, Cappato, R, Ezekowitz, MD, Evers, T, Sahin, K, Kirchhof, P, Meng, IL, van Eickels, M, Camm, AJ, X-VeRT Steering Committee and Investigators

AIMS: We compared patient-reported treatment satisfaction and the economic impact of anticoagulation therapy with rivaroxaban vs. vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation undergoing elective cardioversion procedu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::d1b9ac0345dca0a0c7843a86a2515028